Faktor Risiko Komorbid pada Kematian Covid-19 di Rumah Sakit X Tahun 2021

Authors

  • Masdalena Masdalena Program Studi Magister IKM STIKes Hang Tuah Pekanbaru
  • Irwan Muryanto Program Studi Magister IKM STIKes Hang Tuah Pekanbaru
  • Ahmad Satria Efendi Program Studi Magister IKM STIKes Hang Tuah Pekanbaru
  • Jasrida Yunita Program Studi Magister IKM STIKes Hang Tuah Pekanbaru
  • Tin Gustina Program Studi Magister IKM STIKes Hang Tuah Pekanbaru

DOI:

https://doi.org/10.30872/jkmm.v3i2.7139

Keywords:

COVID-19, Kematian, Komorbid

Abstract

Latar Belakang & Tujuan: Coronavirus Disease (COVID-19) merupakan penyakit yang mengancam kesehatan masyarakat baik internasional dan Indonesia dengan jumlah kasus dan kematian  yang terus meningkat. Pasien  konfirmasi COVID-19 dengan komorbid (penyakit penyerta) merupakan kelompok yang rentan. Penelitian ini bertujuan untuk mengetahui faktor-faktor komorbid yang mempengaruhi risiko kematian penderita COVID-19 di RS X Tahun 2021. Metode: Jenis penelitian ini adalah kuantitatif analitik observasional dengan jenis desain Studi Kasus Kontrol. Teknik pengambilan sampel dengan total sampling untuk sampel kasus 151 dan simple random sampling untuk sampel kontrol 453. Analisa data dengan menggunakan uji regresi logistik. Hasil: Hasil analisis multivariat menunjukkan variabel yang berpengaruh secara signifikan dengan kematian COVID-19 adalah penyakit ginjal, Penyakit Paru Obstruktif Kronis (PPOK), diabetes mellitus, kanker dan kardiovaskuler. Kesimpulan: Bagi masyarakat yang sudah terinfkesi COVID-19 dan disertai penyakit komorbid agar segera memeriksakan diri ke fasilititas pelayanan kesehatan serta segera mendapat penanganan medis, dan bagi masyarakat yang sudah terinfeksi COVID-19 disertai penyakit komorbid, belum dirujuk ke fasilititas pelayanan kesehatan supaya tetap mengontrol penyakit penyerta agar tidak mengalami perburukan dan tetap mematuhi protokol kesehatan.

 

References

Bennett, K. E., Mullooly, M., O’Loughlin, M., Fitzgerald, M., O’Donnell, J., O’Connor, L., Oza, A., & Cuddihy, J. (2021). Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. The Lancet Regional Health - Europe, 5, 100097. https://doi.org/10.1016/j.lanepe.2021.100097

CNN Indonesia. (2020). Cara Mencegah Covid-19 pada Orang dengan Komorbid. Https://Www.Cnnindonesia.Com/Cara-Mencegah-Covid-19-Pada-Orang-Dengan-Komorbid.

Dinas Kesehatan Provinsi Riau. (2021). Riau Tanggap COVID-19. Www.Corona.Go.Id.

dr. Farhanah Meutia, S. (2021). Kelainan Kardiovaskular Akibat COVID-19. Www. Alomedika.Com.

dr. Prima Utami, J. (2021). Risiko Diabstes Mellitus Pasca COVID-19. Www. Alomedika.Com.

Gray, W. K., Navaratnam, A. V, Day, J., Wendon, J., & Briggs, T. W. R. (2021). Changes in COVID-19

in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data. The Lancet Regional Health-Europe, 5, 100104.

Isman, D. (2020). Tanggap Corona Virus bagi Penderita Cancer. Www.ICCC.Id, cek risiko tertular virus corona.

Kemenkes RI. (2014). Situasi kesehatan jantung. Pusat Data Dan Informasi Kementerian Kesehatan RI, 3. https://doi.org/10.1017/CBO9781107415324.004

Kementerian Kesehatan. (2020). Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19) (L. dkk Aziza (ed.); Revisi 5). Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan RI. (2020). Penyakit Kanker dan Kelainan Darah, Hipertensi, Jantung dan Pembuluh Darah, Paru Kronik, Diabetes. Http://Www.P2ptm.Kemkes.Go.Id/Informasi-P2ptm/Penyakit-Kanker-Dan-Kelainan-Darah-Hipertensi-Jangtung-Pembuluh Darah-Paru Kronik-Diabetes.

Lippi, G., & Henry, B. M. (2020). Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19): COPD and COVID-19. Respiratory Medicine, 167(January). https://doi.org/10.1016/j.rmed.2020.105941

Pachiega, J., Afonso, A. J. dos S., Sinhorin, G. T., Alencar, B. T. de, Araújo, M. dos S. M. de, Longhi, F. G., Zanetti, A. D. S., & Espinosa, O. A. (2020). Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil. Revista Do Instituto de Medicina Tropical de São Paulo, 62. https://doi.org/10.1590/S1678-9946202062045

Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M. H., Sarraf, P., & Djalali, M. (2021). Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male, 23(5), 1416–1424. https://doi.org/10.1080/13685538.2020.1774748

Patricia, dr lukas G. (2020). Penyakit Ginjal. Www.Hellosehat.Com/Urologi/Ginjal/Pengertian-Sakit-Ginjal.

Phelps, M., Christensen, D. M., Gerds, T., Fosbøl, E., Torp-Pedersen, C., Schou, M., Køber, L., Kragholm, K., Andersson, C., Biering-Sørensen, T., Christensen, H. C., Andersen, M. P., & Gislason, G. (2021). Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. European Heart Journal - Quality of Care and Clinical Outcomes, 7(2), 172–180. https://doi.org/10.1093/ehjqcco/qcaa081

Ranuseto, dr. A. (2020). Penderita Penyakit Ginjal Terinfeksi COVID-19, Harus Apa? Www.Primayahospital.Com.

Rozaliyani, A., Savitri, A. I., Setianingrum, F., Shelly, T. N., Ratnasari, V., Kuswindarti, R., Salama, N., Oktavia, D., Widyastuti, W., & Handayani, D. (2020). Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Medica Indonesiana, 52(3), 246–254.

Sara, P. R. (2020). Penderita Paru Obstruktif Kronis Rentan Terinfeksi COVID-19. Www.Lifestyle.Kompas.Com.

Satria, R. M. A., Tutupoho, R. V., & Chalidyanto, D. (2020). Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. Jurnal Keperawatan Silampari, 4(1), 48–55. https://doi.org/10.31539/jks.v4i1.1587

Widyawati. (2020). Komorbid jadi penyebab terbanyak kematian pasien COVID-19. Www.Sehatnegeriku.Kemkes.Go.Id.

World Health Organization. (2021). COVID-19 Weekly Epidemiological Update. April 25, 2021. World Health Organization, December, 1–3. https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf

Worldometer. (2021). COVID-19 Coronavirus Pandemic. Www.Worldometer.Info.

Xiao, G., Hu, H., Wu, F., Sha, T., Zeng, Z., Huang, Q., Li, H., Han, J., Song, W., Chen, Z., & Cai, S. (2021). Acute kidney injury in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study. Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University, 41(2), 157–163. https://doi.org/10.12122/j.issn.1673-4254.2021.02.01

Yulianti, A. (2020). Rekomendasi Pengelolaan dan Pencegahan Diabetes di Masa Pandemi COVID-19. Www.Mutupelayanankesehatan.Net.

Zhou, E. W. (2020). 101 Tips Berbasis Sains. Buku Panduan Pencegahan Coronavirus 101 Tips Berbasis Sains Yang Dapat Menyelamatkan Hidup Anda, 120. https://fin.co.id/wp-content/uploads/2020/03/Buku-Panduan-Pencegahan-Coronavirus-101-Tips-Berbasis-Sains.pdf

Zuin, M., Rigatelli, G., Zuliani, G., Rigatelli, A., Mazza, A., & Roncon, L. (2020). Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. Journal of Infection, 81(1), e84–e86.

Vol.3 No.2 Desember 2021

Downloads

Published

2021-12-28

Issue

Vol.3 No.2 Desember (2021) : Jurnal Kesehatan Masyarakat Mulawarman (JKMM)

Section

Research Articles

License

The copyright of this article is transferred to Jurnal Kesehatan Masyarakat Mulawarman (JKMM) and when the article is accepted for publication. The authors transfer all and all rights into and to paper including but not limited to all copyrights in the Jurnal Kesehatan Masyarakat Mulawarman. The author represents and warrants that the original is the original and that he/she is the author of this paper unless the material is clearly identified as the original source, with notification of the permission of the copyright owner if necessary. The author states that he has the authority and authority to make and carry out this task.
The author states that:

  1. This paper has not been published in the same form elsewhere.
  2. This will not be submitted elsewhere for publication prior to acceptance/rejection by this journal.

A Copyright permission is obtained for material published elsewhere and who require permission for this reproduction. Furthermore, I / We hereby transfer the unlimited publication rights of the above paper to Jurnal Kesehatan Masyarakat Mulawarman. Copyright transfer includes exclusive rights to reproduce and distribute articles, including reprints, translations, photographic reproductions, microforms, electronic forms (offline, online), or other similar reproductions.

The author's mark is appropriate for and accepts responsibility for releasing this material on behalf of any and all coauthor. This Agreement shall be signed by at least one author who has obtained the consent of the co-author (s) if applicable. After the submission of this agreement is signed by the author concerned, the amendment of the author or in the order of the author listed shall not be accepted.

Rights / Terms and Conditions Saved

  1. The author keeps all proprietary rights in every process, procedure, or article creation described in Work.
  2. The author may reproduce or permit others to reproduce the work or derivative works for the author's personal use or for the use of the company, provided that the source and the Jurnal Kesehatan Masyarakat Mulawarman copyright notice are indicated, the copy is not used in any way implying the Jurnal Kesehatan Masyarakat Mulawarman (JKMM) approval of the product or service from any company, and the copy itself is not offered for sale.
  3. Although authors are permitted to reuse all or part of the Works in other works, this does not include granting third-party requests to reprint, republish, or other types of reuse.


Article Processing Charge

In order to improve the quality of articles, starting in June 2025 each article to be published in JKMM is subjected to a fee of IDR 550,000 or USD 34.

These fee include the costs of reviewing, translating, proofreading, layout, and publishing articles. Price does not include printed books and postage. The fee will be paid before entering the review process by reviewer.

More information about the Article Processing Charge, please Contact the journal representative through our number in footage information below.